113 related articles for article (PubMed ID: 35487417)
1. Orbital nodular fasciitis in child with biallelic germline RBL2 variant.
Rips J; Abu-Libdeh B; Koplewitz BZ; Kehat-Ophir S; Frenkel S; Elpeleg O; Harel T
Eur J Med Genet; 2022 Jun; 65(6):104513. PubMed ID: 35487417
[TBL] [Abstract][Full Text] [Related]
2. High incidence of allelic loss at 16q12.2 region spanning RBL2/p130 gene in retinoblastoma.
Priya K; Jada SR; Quah BL; Quah TC; Lai PS
Cancer Biol Ther; 2009 Apr; 8(8):714-7. PubMed ID: 19252413
[TBL] [Abstract][Full Text] [Related]
3. RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function.
Samra N; Toubiana S; Yttervik H; Tzur-Gilat A; Morani I; Itzkovich C; Giladi L; Abu Jabal K; Cao JZ; Godley LA; Mory A; Baris Feldman H; Tveten K; Selig S; Weiss K
J Hum Genet; 2021 Nov; 66(11):1101-1112. PubMed ID: 33980986
[TBL] [Abstract][Full Text] [Related]
4. Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2.
Enrico TP; Stallaert W; Wick ET; Ngoi P; Wang X; Rubin SM; Brown NG; Purvis JE; Emanuele MJ
Elife; 2021 Dec; 10():. PubMed ID: 34851822
[TBL] [Abstract][Full Text] [Related]
5. Biallelic loss-of-function variants in RBL2 in siblings with a neurodevelopmental disorder.
Brunet T; Radivojkov-Blagojevic M; Lichtner P; Kraus V; Meitinger T; Wagner M
Ann Clin Transl Neurol; 2020 Mar; 7(3):390-396. PubMed ID: 32105419
[TBL] [Abstract][Full Text] [Related]
6. RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.
Pentimalli F; Forte IM; Esposito L; Indovina P; Iannuzzi CA; Alfano L; Costa C; Barone D; Rocco G; Giordano A
Oncogene; 2018 Jul; 37(27):3657-3671. PubMed ID: 29606701
[TBL] [Abstract][Full Text] [Related]
7. Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.
De Falco G; Leucci E; Lenze D; Piccaluga PP; Claudio PP; Onnis A; Cerino G; Nyagol J; Mwanda W; Bellan C; Hummel M; Pileri S; Tosi P; Stein H; Giordano A; Leoncini L
Blood; 2007 Aug; 110(4):1301-7. PubMed ID: 17485552
[TBL] [Abstract][Full Text] [Related]
8. Promoter Methylation Status Modulate the Expression of Tumor Suppressor (RbL2/p130) Gene in Breast Cancer.
Ullah F; Khan T; Ali N; Malik FA; Kayani MA; Shah ST; Saeed M
PLoS One; 2015; 10(8):e0134687. PubMed ID: 26271034
[TBL] [Abstract][Full Text] [Related]
9. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer.
Kim KB; Kim Y; Rivard CJ; Kim DW; Park KS
Cancer Res; 2020 Nov; 80(22):5051-5062. PubMed ID: 32973083
[TBL] [Abstract][Full Text] [Related]
10. miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.
Liu Z; Gersbach E; Zhang X; Xu X; Dong R; Lee P; Liu J; Kong B; Shao C; Wei JJ
Mol Cancer Res; 2013 Nov; 11(11):1314-25. PubMed ID: 24045973
[TBL] [Abstract][Full Text] [Related]
11. Clinical and neurogenetic characterisation of autosomal recessive RBL2-associated progressive neurodevelopmental disorder.
Aughey G; Cali E; Maroofian R; Zaki MS; Pagnamenta AT; Rahman F; Menzies L; Shafique A; Suri M; Roze E; Aguennouz M; Ghizlane Z; Saadi SM; Ali Z; Abdulllah U; Cheema HA; Anjum MN; Morel G; McFarland R; Altunoglu U; Kraus V; Shoukier M; Murphy D; Flemming K; Yttervik H; Rhouda H; Lesca G; Murtaza BN; Rehman MU; ; Consortium GE; Seo GH; Beetz C; Kayserili H; Krioulie Y; Chung WK; Naz S; Maqbool S; Gleeson J; Baig SM; Efthymiou S; Taylor JC; Severino M; Jepson JE; Houlden H
medRxiv; 2024 May; ():. PubMed ID: 38746364
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of RBL2/p130 in multi-step retinoblastoma tumorigenesis.
Cheah PY
Cancer Biol Ther; 2009 Apr; 8(8):718-9. PubMed ID: 19276650
[No Abstract] [Full Text] [Related]
13. RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.
Duan L; Perez RE; Calhoun S; Maki CG
Sci Rep; 2022 Jan; 12(1):1049. PubMed ID: 35058503
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation.
Mileo AM; Mattarocci S; Matarrese P; Anticoli S; Abbruzzese C; Catone S; Sacco R; Paggi MG; Ruggieri A
J Exp Clin Cancer Res; 2015 Nov; 34():140. PubMed ID: 26576645
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor Rb and its related Rbl2 genes are regulated by Utx histone demethylase.
Terashima M; Ishimura A; Yoshida M; Suzuki Y; Sugano S; Suzuki T
Biochem Biophys Res Commun; 2010 Aug; 399(2):238-44. PubMed ID: 20650264
[TBL] [Abstract][Full Text] [Related]
16. Nucleosomes positioning around transcriptional start site of tumor suppressor (Rbl2/p130) gene in breast cancer.
Farman FU; Iqbal M; Azam M; Saeed M
Mol Biol Rep; 2018 Apr; 45(2):185-194. PubMed ID: 29417345
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
19. MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.
Zhu Y; Gu J; Li Y; Peng C; Shi M; Wang X; Wei G; Ge O; Wang D; Zhang B; Wu J; Zhong Y; Shen B; Chen H
Cancer Lett; 2018 Jan; 412():59-68. PubMed ID: 28987387
[TBL] [Abstract][Full Text] [Related]
20. pRb2/p130: a new candidate for retinoblastoma tumor formation.
De Falco G; Giordano A
Oncogene; 2006 Aug; 25(38):5333-40. PubMed ID: 16936755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]